
Cardiac Electrophysiology and Interventional Medical Device R&D Manufacturer

Minimally Invasive Cardiovascular and Cerebrovascular Interventional Device R&D, Manufacturer, and Distributor
APT Medical (688617.SH) announced that on February 25, 2021, the National Medical Products Administration published the “Notice on Information Regarding Pending Collection of Medical Device Approval Documents (Domestic Production) Dated February 25, 2021” on its website. The company’s wholly-owned subsidiary, APT Medical Inc., obtained a medical device registration certificate.
The announcement indicates that the product is named Hydrophilic Coated Angiographic Catheter, used for injecting or infusing contrast media and/or fluids into blood vessels; it belongs to Class III passive medical devices.
It is reported that the acquisition of the aforementioned medical device registration certificates will help enrich the company’s product portfolio, expand its product layout in the field of vascular access, and continuously meet diverse clinical needs.